Critically, the study lacked a placebo group [7][31]
The compliance angle When we talk about GLP-1 coverage, several compliance touchpoints come into play: Coverage strategies employers are considering Most employers fall into one of three buckets: Of these, the second approach is the most common and arguably the most sustainable for 2026
We do not expect people with diabetes or hypertension to stop their medications after achieving normal readings
Retatrutide reduced WOMAC pain scores by up to 4.5 points (75.8% improvement) at the 9 mg dose and 4.4 points (74.3% improvement) at the 12 mg dose
So when we think about NAD+ Therapy, what you really want to be focusing on is what you'll set yourself up for, explains Dr
Keep it in the refrigerator for best results (main body of the fridge, not the door) Never freeze the medication